Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Optimizing these processes involves adjusting various parameters, including cell line engineering, media ingredients, and bioreactor conditions. A key goal is to increase antibody production while reducing productio